Ann: PTX-100 receives U.S. FDA Fast Track Designation, page-36

Couldn’t have Said this better myself Scotty,
The train has officially left the station with PTX now and the journey has now really begun. Once these next results come in from the current trial that has just started. We will see a dramatic shift in how this company is valued.
We are very happy with the new management and CEO and their clear message for success.

This company has the potential once PTX 100 is approved to go back and put the other lymphoma T cell cancers that we didn’t choose to go into trial (straight to phase 2), also once PTX100 is approved with a licensing deal, we will have the money to finally start Omni Car.

Omni car is what will make this company into a Mid sized pharmaceutical. We are on the cusp of becoming a multibillion-dollar company so my message to everyone, just hold just a little bit longer. There’s nothing negative about this company.